 |
|
|
| |
Lipid Management in a 24-Week, Randomized,
Double-Blind, Placebo-Controlled Study of Aldafermin (NGM282)
|
| |
| |
AASLD 2020 Nov 11-16
Nadege Gunn1, Lei Ling2, Guy Neff3, Cynthia D. Guy4, Mustafa Bashir5, Angelo H. Paredes6, Juan P. Frias7, Ziad Younes8, James F. Trotter9, Sam
E. Moussa10, Anita Kohli11, Margery A. Connelly12, Kristin Nelson2, Mildred Gottwald2, William Chang2, Andrew Z. Yan2, Alex M. DePaoli2,
Hsiao D. Lieu2, Stephen A. Harrison1,13
|
| |
|
|
|
|
|
